Antibody therapy eradicates traces of multiple myeloma in preliminary trial

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted by researchers at Sylvester Comprehensive…

Continue Reading

News Source: medicalxpress.com